Paradigm Biocapital Advisors as of Dec. 31, 2023
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 29 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 13.3 | $284M | 3.9M | 73.59 | |
| Arcellx Common Stock (ACLX) | 9.5 | $203M | 3.7M | 55.50 | |
| Argenx Se Sponsored Adr (ARGX) | 7.5 | $161M | 423k | 380.43 | |
| Disc Medicine (IRON) | 6.5 | $138M | 2.4M | 57.76 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.3 | $114M | 1.9M | 60.17 | |
| Olema Pharmaceuticals (OLMA) | 5.2 | $111M | 7.9M | 14.03 | |
| Miragen Therapeutics (VRDN) | 4.9 | $104M | 4.8M | 21.78 | |
| Immunocore Hldgs Ads (IMCR) | 4.7 | $99M | 1.5M | 68.32 | |
| Cerevel Therapeutics Hldng I (CERE) | 4.6 | $99M | 2.3M | 42.40 | |
| Xenon Pharmaceuticals (XENE) | 4.6 | $98M | 2.1M | 46.06 | |
| Mirati Therapeutics | 4.2 | $91M | 1.5M | 58.75 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.9 | $82M | 2.3M | 35.58 | |
| Autolus Therapeutics Spon Ads (AUTL) | 3.8 | $81M | 13M | 6.44 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.1 | $67M | 3.7M | 18.08 | |
| Ambrx Biopharma Call Option | 3.0 | $64M | 4.5M | 14.24 | |
| Alpine Immune Sciences (ALPN) | 2.8 | $61M | 3.2M | 19.06 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.1 | $44M | 352k | 125.95 | |
| Arvinas Ord (ARVN) | 1.8 | $38M | 931k | 41.16 | |
| Tg Therapeutics (TGTX) | 1.7 | $37M | 2.2M | 17.08 | |
| Zai Lab Adr (ZLAB) | 1.4 | $30M | 1.1M | 27.33 | |
| Immatics SHS (IMTX) | 1.1 | $23M | 2.1M | 10.53 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $21M | 1.0M | 20.25 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $20M | 2.3M | 8.75 | |
| Kura Oncology (KURA) | 0.9 | $18M | 1.3M | 14.38 | |
| Caribou Biosciences (CRBU) | 0.8 | $17M | 2.9M | 5.73 | |
| Vor Biopharma (VOR) | 0.7 | $15M | 6.5M | 2.25 | |
| Cargo Therapeutics (CRGX) | 0.4 | $7.7M | 333k | 23.15 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $6.1M | 400k | 15.15 | |
| Aerovate Therapeutics (AVTE) | 0.2 | $3.2M | 143k | 22.63 |
